122 related articles for article (PubMed ID: 19241619)
1. Molecule of the month. FDA approves new treatment for fibromyalgia.
Lindsley CW
Curr Top Med Chem; 2009; 9(2):225. PubMed ID: 19241619
[No Abstract] [Full Text] [Related]
2. ACS chemical neuroscience molecule spotlight on savella.
Hopkins CR
ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
[TBL] [Abstract][Full Text] [Related]
3. Milnacipran (savella) for fibromyalgia.
Med Lett Drugs Ther; 2009 Jun; 51(1314):45-6. PubMed ID: 19528885
[No Abstract] [Full Text] [Related]
4. Milnacipran for fibromyalgia.
Dempsey J
Issues Emerg Health Technol; 2008 Feb; (114):1-4. PubMed ID: 18354855
[TBL] [Abstract][Full Text] [Related]
5. Drugs to treat fibromyalgia - the transatlantic difference.
Briley M
Curr Opin Investig Drugs; 2010 Jan; 11(1):16-8. PubMed ID: 20047155
[TBL] [Abstract][Full Text] [Related]
6. Neoteric pharmacotherapeutic targets in fibromyalgia.
Chopra K; Kuhad A; Arora V
Expert Opin Ther Targets; 2011 Nov; 15(11):1267-81. PubMed ID: 21905964
[TBL] [Abstract][Full Text] [Related]
7. Fibromyalgia: a new treatment option for fibromyalgia.
Bennett RM
Nat Rev Rheumatol; 2009 Apr; 5(4):188-90. PubMed ID: 19337282
[No Abstract] [Full Text] [Related]
8. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
[TBL] [Abstract][Full Text] [Related]
9. Correction: milnacipran for treatment of fibromyalgia.
Palmer RH
Ann Pharmacother; 2011 Jun; 45(6):827-8; author reply 827. PubMed ID: 21815297
[No Abstract] [Full Text] [Related]
10. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
Arnold LM; Palmer RH; Ma Y
Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
[TBL] [Abstract][Full Text] [Related]
12. A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran.
Toyofuku A; Miyako H
Hum Psychopharmacol; 2004 Jul; 19(5):357-8. PubMed ID: 15252831
[No Abstract] [Full Text] [Related]
13. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
[TBL] [Abstract][Full Text] [Related]
14. Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
Mease PJ; Palmer RH; Wang Y
J Clin Rheumatol; 2014 Jun; 20(4):195-202. PubMed ID: 24847745
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
Arnold LM; Bateman L; Palmer RH; Lin Y
Pediatr Rheumatol Online J; 2015 Jun; 13():27. PubMed ID: 26112278
[TBL] [Abstract][Full Text] [Related]
16. Is milnacipran effective in treating pain in patients with fibromyalgia?
Simon LS
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):126-7. PubMed ID: 16932669
[No Abstract] [Full Text] [Related]
17. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Häuser W; Petzke F; Sommer C
J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study.
Trugman JM; Palmer RH; Ma Y
Curr Med Res Opin; 2014 Apr; 30(4):589-97. PubMed ID: 24188161
[TBL] [Abstract][Full Text] [Related]
19. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
20. Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia.
Saxe PA; Arnold LM; Palmer RH; Gendreau RM; Chen W
Curr Med Res Opin; 2012 May; 28(5):815-21. PubMed ID: 22429066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
